ACGA
Atlanta Consulting Group Advisors’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $311K | Sell |
12,817
-204
| -2% | -$4.95K | 0.09% | 102 |
|
2025
Q1 | $330K | Sell |
13,021
-49
| -0.4% | -$1.24K | 0.1% | 88 |
|
2024
Q4 | $347K | Sell |
13,070
-33,716
| -72% | -$894K | 0.13% | 90 |
|
2024
Q3 | $1.35M | Buy |
46,786
+34,293
| +274% | +$992K | 0.34% | 55 |
|
2024
Q2 | $350K | Buy |
12,493
+1,060
| +9% | +$29.7K | 0.08% | 86 |
|
2024
Q1 | $317K | Buy |
+11,433
| New | +$317K | 0.11% | 97 |
|